Healthcare


 Valneva shares jump 16% after UK government decides to procure 40 mn more vaccine doses

Valneva shares jump 16% after UK government decides to procure 40 mn more vaccine doses

February 01, 2021 12:49 PM GMT| By Kunal Sawhney

Summary Shares of Valneva jumped 16 per cent after the UK government procured 40 million additional doses of its Covid-19 vaccine. After the jump, the shares of Valneva SE hit a fresh all-time high on the .....

 UK May Get Its Fourth Covid-19 Vaccine, Novavax Shows High Efficacy in Phase III Trials

UK May Get Its Fourth Covid-19 Vaccine, Novavax Shows High Efficacy in Phase III Trials

January 31, 2021 12:01 AM GMT| By Team Kalkine Media

Summary                  The new Novavax vaccine has an 86 per cent efficacy against the coronavirus. Novavax will be produced in association with Teesside University in England. The UK has sought 60...

 Siemens Healthineers partners with British hospital trust MFT 

Siemens Healthineers partners with British hospital trust MFT 

January 28, 2021 01:24 PM GMT| By Hina Chowdhary

Summary A 15-year long contract has been signed by both the parties for a financial consideration of EUR 140 million.  Under the agreement, Siemens will provide MFT with an installation of 350 medical equipment. Germany-based&nbs.....

 J&J’s (NYSE: JNJ) Former Talc Supplier Intends to File for Bankruptcy

J&J’s (NYSE: JNJ) Former Talc Supplier Intends to File for Bankruptcy

January 13, 2021 10:34 AM GMT| By Kunal Sawhney

Summary Imerys Talc America talc supplier of J&J is seeking bankruptcy to evade mass litigation matters J&J is awaiting phase 3 trial of its Covid-19 vaccine shortly, which would help in determining the efficacy and safety of the vaccin.....

 What are the recent developments announced by Tiziana Life Sciences on its Covid-19 vaccine clinical trial?

What are the recent developments announced by Tiziana Life Sciences on its Covid-19 vaccine clinical trial?

January 11, 2021 04:31 PM GMT| By Hina Chowdhary

Summary Tiziana Life Sciences had not reported any revenue since its inception. The Company had announced the completion of its clinical study in Brazil investigating nasally administered Foralumab. The Company had completed the demerger of St.....

 Study suggests Pfizer-BioNTech vaccine is effective against new Covid-19 strain

Study suggests Pfizer-BioNTech vaccine is effective against new Covid-19 strain

January 10, 2021 12:05 AM GMT| By Kunal Sawhney

Summary Scientists have found evidence that proves the Pfizer and BioNTech vaccine, BNT162b2, is effective on the mutated version of coronavirus The Pfizer and BioNTech vaccine was the first one to be rolled out in Britain on 8 December A .....

 Covid-19 Vaccine: UK Authorise Moderna Vaccine for Mass Usage

Covid-19 Vaccine: UK Authorise Moderna Vaccine for Mass Usage

January 09, 2021 07:35 AM GMT| By Kunal Sawhney

Summary The UK Government has granted Moderna’s Covid-19 vaccine the Emergency Use Authorization for mass vaccination The Department of Health has said that the Moderna vaccine has met with the strict standards of safety, efficacy and qua.....

 Study claims Roche’s Arthritis Drug can treat Covid-19 patients, UK government gives nod

Study claims Roche’s Arthritis Drug can treat Covid-19 patients, UK government gives nod

January 08, 2021 03:29 PM GMT| By Kunal Sawhney

Summary Two drugs manufactured by Roche’s arthritis drugs -- Tocilizumab and Sarilumab were investigated in a UK-led study  The REMAP-CAP trial has indicated that these medicines are effective in treating severely ill coronavirus pat.....

 Avacta (LON: AVCT) Group Enters Licence Agreement with Point Biopharma

Avacta (LON: AVCT) Group Enters Licence Agreement with Point Biopharma

January 07, 2021 12:41 PM GMT| By Team Kalkine Media

Summary Avacta Group has joined forces with Point Biopharma Inc to accelerate the progress of tumour-activated radiopharmaceuticals The agreement will lead to proceeds of $9.5 million to Avacta Group, which comprises of an upfront fee and devel.....

 AstraZeneca (LON: AZN) vaccine rollout gets extended to general practitioners

AstraZeneca (LON: AZN) vaccine rollout gets extended to general practitioners

January 07, 2021 07:26 AM GMT| By Team Kalkine Media

Summary Government aims to vaccinate all the four most vulnerable groups within the next one and a half months’ period The UK’s National Health Service (NHS) has informed that some doctors’ practices would be able to offer.....

 AstraZeneca PLC’s (LON: AZN) Farxiga Secures US Priority Review

AstraZeneca PLC’s (LON: AZN) Farxiga Secures US Priority Review

January 06, 2021 04:58 PM GMT| By Kunal Sawhney

Summary AstraZeneca announced that it has been granted the Priority Review in the US foe Farxiga If approved, Farxiga (dapagliflozin) could be used in treating the patients of chronic kidney disease AstraZeneca PLC (LON: AZN) announce.....

 What’s in store for Healthcare Stocks in 2021: Top 5 picks 

What’s in store for Healthcare Stocks in 2021: Top 5 picks 

January 01, 2021 12:27 AM GMT| By Hina Chowdhary

Healthcare companies are active all year round irrespective of the global situation; hence it is always considered good to have a decent exposure in the healthcare stocks if one is making a portfolio. It is also considered as a popular trend, particu...

 After UK’s Approval, Mexico May Go Ahead with AstraZeneca-Oxford University Vaccine

After UK’s Approval, Mexico May Go Ahead with AstraZeneca-Oxford University Vaccine

December 31, 2020 10:49 AM GMT| By Team Kalkine Media

Summary Britain's approval of Oxford University and AstraZeneca’s coronavirus vaccine candidate, which was developed in record time, was hailed by Mexico's government Latin American nations such as Mexico, Argentina, and Chile are very cl.....

 Oxford University- AstraZeneca (LON: AZN) Covid-19 Vaccine Gets UK Regulator’s Nod

Oxford University- AstraZeneca (LON: AZN) Covid-19 Vaccine Gets UK Regulator’s Nod

December 30, 2020 09:20 AM GMT| By Kunal Sawhney

Summary MHRA has authorised Oxford University-AstraZeneca for emergency use of their COVID-19 Vaccine AstraZeneca’s vaccine achieved an overall efficacy level of 70 per cent The British drugmaker is closely working with the Public H.....

 AstraZeneca (LON: AZN) Receives US Approval for Lung Cancer Treatment

AstraZeneca (LON: AZN) Receives US Approval for Lung Cancer Treatment

December 22, 2020 08:30 AM GMT| By Kunal Sawhney

Summary AstraZeneca plc’s (LON: AZN) Tagrisso (osimertinib) has received approval in the US for the adjuvant medication of adult patients. The approval was received under the US Food and Drug Administration’s (FDA) Real-Time Oncolog.....

 Moderna Very Close to Getting US FDA Emergency Approval for Its Vaccine

Moderna Very Close to Getting US FDA Emergency Approval for Its Vaccine

December 18, 2020 11:24 AM GMT| By Hina Chowdhary

Summary On 17 December, a panel of independent US experts recommended the emergency approval for Moderna’s mRNA-based vaccine. Last week, the same panel had backed the Pfizer Inc/BioNTech SE vaccine. The Moderna vaccine has efficiency an.....

 AstraZeneca (LON: AZN) UK Vaccine Trial Withdraw Sub-Group

AstraZeneca (LON: AZN) UK Vaccine Trial Withdraw Sub-Group

December 15, 2020 09:07 AM GMT| By Hina Chowdhary

Summary The clinical trial registers in the US showed that the British pharma major AstraZeneca PLC has removed children from the final stage trial of its Covid-19 vaccine in Britain. The Phase 3 trial of the vaccine consisted of more than 12,0.....

 Will the US Face Critical Shortage of Covid-19 Vaccine Doses?

Will the US Face Critical Shortage of Covid-19 Vaccine Doses?

December 15, 2020 08:42 AM GMT| By Team Kalkine Media

There has been a wave of jubilation in the US after the Food and Drug Administration (FDA) granted the emergency use authorisation for the coronavirus vaccine co-developed by Pfizer Inc and BioNTech SE. As the US has the highest number of reported .....

 US FDA allows Pfizer-BioNTech Covid-19 vaccine for emergency use

US FDA allows Pfizer-BioNTech Covid-19 vaccine for emergency use

December 12, 2020 09:53 AM GMT| By Kunal Sawhney

  The US Food and Drug Administration (FDA) on Friday gave a go-ahead to Pfizer-BioNTech COVID-19 Vaccine for emergency use in the US. The FDA in a statement said that it is determined that Pfizer-BioNTech’s vaccine has met its statutor.....

 Why GSK (LON: GSK) and Sanofi's (EPA: SAN) Covid-19 vaccine got delayed to 2021-end?

Why GSK (LON: GSK) and Sanofi's (EPA: SAN) Covid-19 vaccine got delayed to 2021-end?

December 12, 2020 08:11 AM GMT| By Kunal Sawhney

Summary The Covid-19 vaccine jointly developed by Britain’s GSK and France’s Sanofi has been delayed to the end of 2021 Both the pharmaceutical companies are expected to start Phase 2b studies in February 2021 While the compani.....

Recent Articles






Investing Tips

Previous Next